Patent Dispute Ends Between Pharma Majors

The lupin trademark case has officially been resolved through a negotiated settlement. The agreement permits Lupin to continue selling its generic bladder treatment drug under defined licensing conditions. By settling the dispute, both pharmaceutical companies have reduced legal risks and secured greater business stability.
Read More: https://analystip.com/lupin-an....d-astellas-patent-di